Dr. Rasha Kelej meets The First Lady of Nigeria & 6 African First Ladies of Africa at the 12th Africa Asia Luminary 2025 in ...

USA-based mRNA vaccines company Moderna’s shares were flat in pre-market activity, as the company announced awaited new ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a multi-year collaboration with ...

The original is 6 stories and holds 1,500 cars: the new one is only 4 stories and 500 cars,” said Merck spokesman Greg Landis.

Find insight on Merck KGaA, Indonesia’s B50 policy, IJM Corp. and more in the latest Market Talks covering ESG Impact ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its fourth-quarter and full-year 2025 ...

United Arab Emirates: The Ministry of Health and Prevention (MoHAP), in collaboration with Merck Gulf, showcased the results ...

With star checkpoint inhibitors like Keytruda and Opdivo now sporting subcutaneous formulations, GSK has struck a deal aimed ...

Invesco Equity and Income Fund lagged its benchmark in Q4 2025 as IT and fixed income weighed. See new holdings and full ...

US pharma major Merck & Co is trying to make its looming Keytruda (pembrolizumab) patent hill look more like a speed bump.

A combination of intismeran autogene and Keytruda significantly prolonged recurrence-free survival in melanoma.

In December 2025, pimicotinib was approved by the China National Medical Products Administration (NMPA) for the treatment of adult patients with symptomatic TGCT for which surgical resection will ...